“John is uniquely qualified to continue the transformation of our Life Science business,” said Jonathan DiVincenzo, President of Millipore’s Bioscience Division. “His success in the areas of strategy and business development will be invaluable in our efforts to bring innovative new products and solutions to our customers working in protein research and cell biology.”

Sweeney joined Millipore in 2003 as Director of Strategy and Corporate Development. In that role, he was responsible for long range strategic planning and served as the lead on execution of key M&A and partnership transactions, including Millipore’s $1.4 billion acquisition of Serologicals.

“Millipore has a tremendous opportunity to help our customers advance significant scientific research that could ultimately cure some of the world’s most challenging human health issues,” said Sweeney. “Our goal is to continue to create true solutions to customer problems through the introduction of cutting-edge devices, instruments and reagents that meet the rapidly changing needs of scientists"

In his most recent role, Sweeney transformed Millipore's web presence, generating double-digit growth. He also built the Bioscience Business Development team which has resulted in several innovation partnerships and the acquisitions of Guava and Epitome.

“Creating new partnerships and developing new technologies are both crucial to Millipore’s continued growth.” added Sweeney. “I look forward to furthering that growth in our life science business.”

Sweeney is a graduate of the University of Pennsylvania and earned a Master of Business Administration degree from the Tuck School of Business at Dartmouth.

About Millipore
Millipore (NYSE: MIL) is a Life Science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world’s challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. Millipore Corporation is an S&P 500 company with more than 5,900 employees worldwide. For more information, visit www.millipore.com.

ADVANCING LIFE SCIENCE TOGETHER™
Research. Development. Production.

Media Contact:
Karen Marinella Hall
Director of Corporate Communications
(978) 715-1567
karen_hall@millipore.com

For Investors:
Joshua Young
Director, Investor Relations
(978) 715-1527
joshua_young@millipore.com